Psyence Group Stock Performance
| PSYGF Stock | USD 0.13 0.00 0.00% |
On a scale of 0 to 100, Psyence holds a performance score of 13. The company holds a Beta of -0.38, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Psyence are expected to decrease at a much lower rate. During the bear market, Psyence is likely to outperform the market. Please check Psyence's standard deviation, as well as the relationship between the maximum drawdown and day median price , to make a quick decision on whether Psyence's historical price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Psyence Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Psyence reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 124.5 K | |
| Total Cashflows From Investing Activities | -311.5 K |
Psyence |
Psyence Relative Risk vs. Return Landscape
If you would invest 9.92 in Psyence Group on September 29, 2025 and sell it today you would earn a total of 3.08 from holding Psyence Group or generate 31.05% return on investment over 90 days. Psyence Group is currently producing 0.4404% returns and takes up 2.5908% volatility of returns over 90 trading days. Put another way, 23% of traded pink sheets are less volatile than Psyence, and 92% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Psyence Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Psyence's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Psyence Group, and traders can use it to determine the average amount a Psyence's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.17
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PSYGF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Psyence is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Psyence by adding it to a well-diversified portfolio.
Psyence Fundamentals Growth
Psyence Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Psyence, and Psyence fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psyence Pink Sheet performance.
| Return On Equity | -1.66 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (787.36) % | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 93.28 M | |||
| Price To Book | 1.93 X | |||
| Price To Sales | 1,359 X | |||
| EBITDA | (4.55 M) | |||
| Cash And Equivalents | 2.32 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.84 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (3.56 M) | |||
| Earnings Per Share | (0.14) X | |||
| Total Asset | 4.35 M | |||
About Psyence Performance
By analyzing Psyence's fundamental ratios, stakeholders can gain valuable insights into Psyence's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Psyence has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Psyence has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada. Psyence is traded on OTC Exchange in the United States.Things to note about Psyence Group performance evaluation
Checking the ongoing alerts about Psyence for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Psyence Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Psyence Group has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.6 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Psyence Group has accumulated about 2.32 M in cash with (3.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. |
- Analyzing Psyence's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psyence's stock is overvalued or undervalued compared to its peers.
- Examining Psyence's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Psyence's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psyence's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Psyence's pink sheet. These opinions can provide insight into Psyence's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Psyence Pink Sheet analysis
When running Psyence's price analysis, check to measure Psyence's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence is operating at the current time. Most of Psyence's value examination focuses on studying past and present price action to predict the probability of Psyence's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence's price. Additionally, you may evaluate how the addition of Psyence to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |